Cargando…

Neprilysin is a Mediator of Alternative Renin-Angiotensin-System Activation in the Murine and Human Kidney

Cardiovascular and renal pathologies are frequently associated with an activated renin-angiotensin-system (RAS) and increased levels of its main effector and vasoconstrictor hormone angiotensin II (Ang II). Angiotensin-converting-enzyme-2 (ACE2) has been described as a crucial enzymatic player in sh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Domenig, Oliver, Manzel, Arndt, Grobe, Nadja, Königshausen, Eva, Kaltenecker, Christopher C., Kovarik, Johannes J., Stegbauer, Johannes, Gurley, Susan B., van Oyen, Dunja, Antlanger, Marlies, Bader, Michael, Motta-Santos, Daisy, Santos, Robson A., Elased, Khalid M., Säemann, Marcus D., Linker, Ralf A., Poglitsch, Marko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030486/ https://www.ncbi.nlm.nih.gov/pubmed/27649628 http://dx.doi.org/10.1038/srep33678

Ejemplares similares

Molecular remodeling of the renin-angiotensin system after kidney transplantation
por: Antlanger, Marlies, et al.
Publicado: (2017)

Intrarenal Renin-Angiotensin-System Dysregulation after Kidney Transplantation
por: Kovarik, Johannes J., et al.
Publicado: (2019)

Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory Study
por: Kovarik, Johannes J., et al.
Publicado: (2021)

Combined sodium glucose co‐transporter‐2 inhibitor and angiotensin‐converting enzyme inhibition upregulates the renin‐angiotensin system in chronic kidney disease with type 2 diabetes: Results of a randomized, double‐blind, placebo‐controlled exploratory trial
por: Antlanger, Marlies, et al.
Publicado: (2022)

A randomized controlled trial-based algorithm for insulin-pump therapy in hyperglycemic patients early after kidney transplantation
por: Werzowa, Johannes M., et al.
Publicado: (2018)

Fluid overload in hemodialysis patients: a cross-sectional study to determine its association with cardiac biomarkers and nutritional status
por: Antlanger, Marlies, et al.
Publicado: (2013)

Effects of neprilysin-renin inhibition in comparison with neprilysin-angiotensin inhibition on the neurohumoral changes in rats with heart failure
por: Dizaye, Kawa, et al.
Publicado: (2019)

Safety of the neprilysin/renin-angiotensin system inhibitor LCZ696
por: Li, Bo, et al.
Publicado: (2017)

Effects of Angiotensin II Type 1A Receptor on ACE2, Neprilysin and KIM-1 in Two Kidney One Clip (2K1C) Model of Renovascular Hypertension
por: Alawi, Laale F., et al.
Publicado: (2021)

Effect of hyperglycemia and rosiglitazone on renal and urinary neprilysin in db/db diabetic mice
por: Alawi, Laale F., et al.
Publicado: (2020)

Vascular pathology in multiple sclerosis: mind boosting or myth busting?
por: Waschbisch, Anne, et al.
Publicado: (2011)

Dipeptidyl peptidase 3 modulates the renin–angiotensin system in mice
por: Jha, Shalinee, et al.
Publicado: (2020)

Recombinant Expression and Characterization of Human and Murine ACE2: Species-Specific Activation of the Alternative Renin-Angiotensin-System
por: Poglitsch, Marko, et al.
Publicado: (2012)

The effect of neprilysin and renin inhibition on the renal dysfunction following ischemia‐reperfusion injury in the rat
por: Hammad, Fayez T., et al.
Publicado: (2021)

The systemic and hepatic alternative renin–angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammation
por: Hartl, Lukas, et al.
Publicado: (2023)

Impact of Systemic Volume Status on Cardiac Magnetic Resonance T1 Mapping
por: Antlanger, Marlies, et al.
Publicado: (2018)

Loss of Prolyl Carboxypeptidase in Two-Kidney, One-Clip Goldblatt Hypertensive Mice
por: Grobe, Nadja, et al.
Publicado: (2015)

Abdominal Aortic Aneurysm Detection in Bioelectrical Impedance Cardiovascular Screenings—A Pilot Study
por: Hofmann, Amun G., et al.
Publicado: (2023)

Combined Inhibition of the Renin-Angiotensin System and Neprilysin Positively Influences Complex Mitochondrial Adaptations in Progressive Experimental Heart Failure
por: Grois, Laura, et al.
Publicado: (2017)

Effect of Angiotensin–Neprilysin Versus Renin–Angiotensin System Inhibition on Renal Outcomes: A Systematic Review and Meta-Analysis
por: Xu, Ying, et al.
Publicado: (2021)

Neprilysin in HFrEF: Differential Regulation of Tissue Versus Circulating Neprilysin
por: Chen, Horng H., et al.
Publicado: (2020)

Identification and bioinformatic analysis of neprilysin and neprilysin-like metalloendopeptidases in Drosophila melanogaster
por: Meyer, Heiko, et al.
Publicado: (2021)

Empagliflozin in posttransplantation diabetes mellitus: A prospective, interventional pilot study on glucose metabolism, fluid volume, and patient safety
por: Schwaiger, Elisabeth, et al.
Publicado: (2019)

Neprilysin Inhibitors and Bradykinin
por: Campbell, Duncan J.
Publicado: (2018)

Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI)
por: Königsbrügge, Oliver, et al.
Publicado: (2017)

Role of glial 14-3-3 gamma protein in autoimmune demyelination
por: Lee, De-Hyung, et al.
Publicado: (2015)

Effects of neprilysin and neprilysin inhibitors on glucose homeostasis: Controversial points and a promising arena
por: AlAnazi, Faisal Holil, et al.
Publicado: (2023)

The systemic renin-angiotensin system in COVID-19
por: Reindl-Schwaighofer, Roman, et al.
Publicado: (2022)

Neprilysin, obesity and the metabolic syndrome
por: Standeven, Kristina F., et al.
Publicado: (2010)

Angiotensin II increases glomerular permeability by β-arrestin mediated nephrin endocytosis
por: Königshausen, Eva, et al.
Publicado: (2016)

Circulating renin‐angiotensin‐aldosterone system activity in cats with systemic hypertension or cardiomyopathy
por: Ward, Jessica L., et al.
Publicado: (2022)

The Role of Neprilysin in Regulating the Hair Cycle
por: Morisaki, Naoko, et al.
Publicado: (2013)

Neprilysin inhibition in chronic kidney disease
por: Judge, Parminder, et al.
Publicado: (2015)

Urinary neprilysin in the critically ill patient
por: Pajenda, Sahra, et al.
Publicado: (2017)

Neprilysin as a Biomarker: Challenges and Opportunities
por: Pavo, Noemi, et al.
Publicado: (2020)

Angiotensin receptor blocker neprilysin inhibitors
por: Usuda, Daisuke, et al.
Publicado: (2021)

Relevance of Neutrophil Neprilysin in Heart Failure
por: Prausmüller, Suriya, et al.
Publicado: (2021)

Evaluation of Renin–Angiotensin–Aldosterone System Components and Enzymes in Systemically Hypertensive Cats Receiving Amlodipine
por: Adin, Darcy, et al.
Publicado: (2023)

Neprilysin-dependent neuropeptide Y cleavage in the liver promotes fibrosis by blocking NPY-receptor 1
por: Ortiz, Cristina, et al.
Publicado: (2023)

Suspected primary hyperreninism in a cat with malignant renal sarcoma and global renin‐angiotensin‐aldosterone system upregulation
por: Evans, Jeremy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ihn0g6elvtj8r5ud6nu6l5322q